Clienvo eTMF Description
Clinevo's electronic Trial Master File (eTMF) is a user-friendly digital solution for the organization and storage of documents, images, and various digital assets related to clinical trials. This eTMF incorporates an integrated DIA reference model and complies with regulatory standards. Additionally, Clinevo offers the MICC Intake, a web-based platform designed for Medical Information Call Centers (MICC) and Pharmacovigilance (PV) professionals to efficiently log, track, and monitor Product Quality Complaints (PQCs), Medical Inquiries (MIs), and Adverse Events (AEs). Furthermore, Clinevo Safety serves as a comprehensive cloud-based system that ensures ease of use and regulatory compliance throughout the entire Pharmacovigilance process, encompassing PV Intake, Case Processing, Regulatory Submissions/AS2 Gateway, Analytics, and Safety Signals, all within a single platform. Lastly, the Clinevo Website Intake tool can seamlessly integrate with Sponsor or CRO websites, offering consumers and reporters an intuitive web interface for easy access and reporting. This innovative suite of tools enhances the efficiency and effectiveness of clinical trial management and safety reporting.
Integrations
Company Details
Product Details
Clienvo eTMF Features and Options
Clienvo eTMF Lists
Clienvo eTMF User Reviews
Write a Review-
Likelihood to Recommend to Others1 2 3 4 5 6 7 8 9 10
Very User friendly, Cost effective and Cloud based platform. Date: May 22 2021
Summary: It's a great tool that can be integrated easily with other platforms and also very cost-effective.
Positive: The platform is simple & easy to use.
Documents are pretty easy to search.
The software comes with a prebuilt DIA reference model.
It provides advanced analytics to track Completeness, Quality, Timeliness.
The best feature is this platform can be easily integrated with CDMS/ CTMS systems.
It also has the feature of uploading hundreds of documents in one go using a simple drag and drop.Negative: Haven't found any problem till the date. So, no cons as Such.
Read More...
- Previous
- You're on page 1
- Next